Depression News and Research

Latest Depression News and Research

Alkermes initiates pivotal clinical development program for treatment of MDD

Alkermes plc today announced the initiation of the pivotal clinical development program for ALKS 5461, a once-daily, oral investigational medicine with a novel mechanism of action for the adjunctive treatment of major depressive disorder (MDD).

6 Mar 2014

Scientists recommend psychological counselling to help patients remain active till donor heart is found

For many people with advanced cardiac insufficiency, a heart transplant may be their only hope. But waiting for a donor heart to come along is a race against time.

6 Mar 2014

Adolescents, young adults who fall victim to IPV more likely to experience depressive symptoms

Described by the Centers for Disease Control and Prevention as "physical, sexual, or psychological harm by a current or former partner or spouse," intimate partner violence (IPV) is a serious public health issue affecting millions of people in the United States. New research from sociologists at Bowling Green State University shows that adolescents and young adults who perpetrate or fall victim to IPV are more likely to experience an increase in symptoms of depression.

6 Mar 2014

Research shows how patient experiences can be used to improve healthcare

A research project led by Oxford University is showing how patient experiences can be used to improve healthcare - not through targets and surveys, but by getting doctors, nurses and patients talking together about care on the ward.

6 Mar 2014

Diagnostic errors common among patients with bipolar disorder

Russian study data bolster the existing body of evidence showing that bipolar disorder is often misdiagnosed as depression.

5 Mar 2014

Haiti HIV program increases sexual health awareness and practices in women

New research from the University of Toronto shows that a little training can go a long way in a desperate situation.

5 Mar 2014

UTHealth study to assess deep brain stimulation for treatment-resistant depression

A pilot study at The University of Texas Health Science Center at Houston (UTHealth) will assess the use of deep brain stimulation (DBS) in the medial forebrain bundle of the brain for treatment-resistant depression.

5 Mar 2014

Study: Nearly 1 in 5 had mental illness before military enlistment

The findings, published as three papers in JAMA Psychiatry, show that soldiers who join the military come in with much higher rates of mental illness than the general public.

5 Mar 2014

Psychological support should be a priority for diabetes care in the UK

Study results announced today by Novo Nordisk and collaborative partners at the Diabetes UK conference show psychological support should be a priority for diabetes care in the UK, alongside improved education and self-management of the condition.

5 Mar 2014

New uses of imaging technologies could help scientists uncover brain's mysteries

Combining two imagine technologies, such as MRI for structure and MEG for activity, could provide a new understanding of our how our brain works.

4 Mar 2014

First Edition: March 4, 2014

Today's headlines include highlights and themes from President Barack Obama's 2015 budget to be released today.

4 Mar 2014

Outbursts of anger may trigger heart attacks and strokes, shows study

Outbursts of anger may trigger heart attacks, strokes and other cardiovascular problems in the two hours immediately afterwards, according to the first study to systematically evaluate previous research into the link between the extreme emotion and all cardiovascular outcomes.

4 Mar 2014

Intra-Cellular Therapies initiates Phase I/II clinical trial to evaluate pharmacokinetics in patients with dementia

Intra-Cellular Therapies, Inc., a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced the initiation of ITI-007-200, a Phase I/II clinical trial designed to evaluate the safety, tolerability and pharmacokinetics of low doses of its lead drug candidate, ITI-007, in healthy geriatric subjects and in patients with dementia, including Alzheimer's disease.

4 Mar 2014

Naurex's GLYX-13 receives FDA Fast Track designation

Naurex Inc. today announced that the U.S. Food and Drug Administration has granted Fast Track designation to the investigation of GLYX-13, the company's rapid-acting antidepressant in Phase 2 clinical development, as adjunctive therapy in major depressive disorder.

4 Mar 2014

Yoga offers unique benefits for women with breast cancer undergoing radiation therapy

For women with breast cancer undergoing radiation therapy, yoga offers unique benefits beyond fighting fatigue, according to research from The University of Texas MD Anderson Cancer Center.

4 Mar 2014

Insomnia behaviours independently influence sleep in mood disorders

Behaviours associated with controlling sleep and managing the negative effects of insomnia are independently associated with disturbed sleep in patients with anxiety or depressive disorders, US research shows.

3 Mar 2014

New article explores risks associated with using herbal cannabis for rheumatic conditions

Patients with rheumatic conditions are in need of symptom relief and some are turning to herbal cannabis as a treatment option. However, the effectiveness and safety of medical marijuana to treat symptoms of rheumatic conditions such as rheumatoid arthritis, lupus, or fibromyalgia is not supported by medical evidence. A new article published in Arthritis Care & Research, a journal of the American College of Rheumatology, explores the risks associated with using herbal cannabis for medicinal purposes and advises healthcare providers to discourage rheumatology patients from using this drug as therapy.

3 Mar 2014

Five women scientists to receive ‘L’Oréal-UNESCO For Women in Science Awards'

On March 19th the L'Oréal Foundation and UNESCO will present the L'Oréal-UNESCO For Women in Science awards to five outstanding women scientists.

3 Mar 2014

Photoreactive compounds open new routes to treatment of neurological diseases

Photoreactive compounds developed by scientists of Ludwig-Maximilians-Universitaet (LMU) in Munich directly modulate nerve-cell function, and open new routes to the treatment of neurological diseases, including chronic pain and certain types of visual impairment.

3 Mar 2014